The strategic acquisition reinforces Sebia’s product portfolio & strategy in autoimmunity
Educational Webinar with Katie Thoren, PhD, Memorial Sloan Kettering Cancer Center
Sebia to acquire a minority stake in Metafora biosystems.
Educational Webinar with Prof. Alessandro Gozzetti, MD, PhD
Immunotherapies for Multiple Myeloma, like the monoclonal antibody daratumumab, can create false positive IgG Kappa bands on Immunofixation gels. This paper describes best practice guidelines for using the Hydrashift assay to remove daratumumab interference from Immunofixation gels.
The strategic acquisition reinforces Sebia’s global leadership in specialty diagnostics.
With this short video report, become aware of all the benefits of partnering with Sebia and integrate your capillary electrophoresis into the lab track automation.